MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (MRNS)

Historical Holders from Q3 2020 to Q2 2025

Symbol
MRNS
Type / Class
Equity / COMMON STOCK
Shares outstanding
54.7M
All holders as of 30 Jun 2025
Q2 2025
Total 13F shares, excl. options
6K
Holdings value
$3.24K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
1
Number of buys
1
Average Value change %
0%
Average buys %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (MRNS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUVRETTA CAPITAL MANAGEMENT, LLC 5.5% +42.5% $1.66M $505K 3.02M +43.6% SUVRETTA CAPITAL MANAGEMENT, LLC 07 Feb 2025
VANGUARD GROUP INC 4.7% $1.43M 2.6M The Vanguard Group 31 Dec 2024
TANG CAPITAL PARTNERS LP 3% $903K 1.64M TANG CAPITAL MANAGEMENT, LLC 31 Dec 2024

Institutional Holders of MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (MRNS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 6K $3.24K +$3.24K $0.54 1
2025 Q1 0 $0 -$15.8M 0
2024 Q4 29.5M $15.8M -$30.4M $0.54 51
2024 Q3 41.4M $72.9M -$1.83M $1.76 72
2024 Q2 43.3M $50.6M -$154M $1.17 87
2024 Q1 53.8M $486M -$1.48M $9.04 112
2023 Q4 53.8M $585M +$27.8M $10.87 104
2023 Q3 51.1M $411M +$48.3M $8.05 102
2023 Q2 44.7M $485M +$47.7M $10.86 104
2023 Q1 41.1M $284M +$27.9M $6.90 85
2022 Q4 36.2M $144M +$42.9M $3.98 71
2022 Q3 25.2M $168M +$2.3M $6.65 64
2022 Q2 28.8M $141M -$8M $4.84 67
2022 Q1 30M $280M -$1.23M $9.35 82
2021 Q4 29.9M $356M -$20.5M $11.88 73
2021 Q3 31.8M $362M -$2.69M $11.38 78
2021 Q2 31.4M $563M +$7.46M $17.94 79
2021 Q1 31M $480M +$31.1M $15.48 85
2020 Q4 29.5M $360M +$131M $12.20 82
2020 Q3 18.6M $239M +$239M $12.85 73